Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors.
Talbot SM, Westerman DA, Grigg AP, Toner GC, Wolf M, Bishop J, McKendrick J, Zalcberg J, Levi J, Fox RM, Green MD. Talbot SM, et al. Among authors: mckendrick j. Ann Oncol. 1999 Aug;10(8):907-14. doi: 10.1023/a:1008353522601. Ann Oncol. 1999. PMID: 10509151 Free article. Clinical Trial.
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.
Maher DW, Lieschke GJ, Green M, Bishop J, Stuart-Harris R, Wolf M, Sheridan WP, Kefford RF, Cebon J, Olver I, McKendrick J, Toner G, Bradstock K, Lieschke M, Cruickshank S, Tomita DK, Hoffman EW, Fox RM, Morstyn G. Maher DW, et al. Among authors: mckendrick j. Ann Intern Med. 1994 Oct 1;121(7):492-501. doi: 10.7326/0003-4819-121-7-199410010-00004. Ann Intern Med. 1994. PMID: 7520676 Clinical Trial.
A phase II trial of paclitaxel and epirubicin in advanced breast cancer.
Rischin D, Smith J, Millward M, Lewis C, Boyer M, Richardson G, Toner G, Gurney H, McKendrick J. Rischin D, et al. Among authors: mckendrick j. Br J Cancer. 2000 Aug;83(4):438-42. doi: 10.1054/bjoc.2000.1306. Br J Cancer. 2000. PMID: 10945487 Free PMC article. Clinical Trial.
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
Mead GM, Sydes MR, Walewski J, Grigg A, Hatton CS, Pescosta N, Guarnaccia C, Lewis MS, McKendrick J, Stenning SP, Wright D; UKLG LY06 collaborators. Mead GM, et al. Among authors: mckendrick j. Ann Oncol. 2002 Aug;13(8):1264-74. doi: 10.1093/annonc/mdf253. Ann Oncol. 2002. PMID: 12181251 Free article. Clinical Trial.
Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.
Michael M, Chander S, McKendrick J, MacKay JR, Steel M, Hicks R, Heriot A, Leong T, Cooray P, Jefford M, Zalcberg J, Bressel M, McClure B, Ngan SY. Michael M, et al. Among authors: mckendrick j. Br J Cancer. 2014 Nov 11;111(10):1924-31. doi: 10.1038/bjc.2014.487. Epub 2014 Sep 11. Br J Cancer. 2014. PMID: 25211659 Free PMC article. Clinical Trial.
Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age.
Mileshkin L, Biagi JJ, Mitchell P, Underhill C, Grigg A, Bell R, McKendrick J, Briggs P, Seymour JF, Lillie K, Smith JG, Zeldis JB, Prince HM. Mileshkin L, et al. Among authors: mckendrick j. Blood. 2003 Jul 1;102(1):69-77. doi: 10.1182/blood-2002-09-2846. Epub 2003 Mar 13. Blood. 2003. PMID: 12637329 Free article. Clinical Trial.
156 results